These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30276588)

  • 41. Sidedness is not a prognostic factor in an unselected cohort of patients with colon cancer but prognosis for caecal carcinoma is worse - A multivariate analysis of a large single institution database.
    Stelzner S; Mehdorn M; Puffer E; Bleyl D; Kittner T; Rhode P; Gockel I; Mees ST
    Int J Colorectal Dis; 2024 Feb; 39(1):27. PubMed ID: 38349566
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between Primary Tumor Location and Prognostic Survival in Synchronous Colorectal Liver Metastases after Surgical Treatment: A Retrospective Analysis of SEER Data.
    Wang Z; Wang X; Zhang Z; Wang X; Chen M; Lu L; Zhu W; Zhang J; Jia H; Chen J
    J Cancer; 2019; 10(7):1593-1600. PubMed ID: 31205514
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The KRAS G12D mutation increases the risk of unresectable recurrence of resectable colorectal liver-only metastasis.
    Chen K; Okamura Y; Hatakeyama K; Shiomi A; Kagawa H; Hino H; Manabe S; Yamaoka Y; Sugiura T; Sugino T; Notsu A; Nagashima T; Ohshima K; Urakami K; Akiyama Y; Yamaguchi K
    Surg Today; 2024 Jul; ():. PubMed ID: 39083120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis.
    Lohinai Z; Klikovits T; Moldvay J; Ostoros G; Raso E; Timar J; Fabian K; Kovalszky I; Kenessey I; Aigner C; Renyi-Vamos F; Klepetko W; Dome B; Hegedus B
    Sci Rep; 2017 Jan; 7():39721. PubMed ID: 28051122
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biology of Nodal Spread in Colon Cancer: Insights from Molecular and Genetic Studies.
    Kandagatla P; Maguire LH; Hardiman KM
    Eur Surg Res; 2018; 59(5-6):361-370. PubMed ID: 30537705
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Effects of Primary Tumor Location on Survival after Liver Resection for Colorectal Liver Metastasis in the Mediterranean Population.
    Mahamid A; Abu-Zaydeh O; Kazlow E; Froylich D; Sawaied M; Goldberg N; Berger Y; Khoury W; Sadot E; Haddad R
    J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629285
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trends in incidence of infrequent and frequent synchronous metastases from colorectal cancer.
    Jooste V; Lepage C; Manfredi S; Bouvier AM
    Dig Liver Dis; 2024 Jul; ():. PubMed ID: 38972790
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial.
    Bridgewater JA; Pugh SA; Maishman T; Eminton Z; Mellor J; Whitehead A; Stanton L; Radford M; Corkhill A; Griffiths GO; Falk S; Valle JW; O'Reilly D; Siriwardena AK; Hornbuckle J; Rees M; Iveson TJ; Hickish T; Garden OJ; Cunningham D; Maughan TS; Primrose JN;
    Lancet Oncol; 2020 Mar; 21(3):398-411. PubMed ID: 32014119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancer.
    Jo P; Bernhardt M; Nietert M; König A; Azizian A; Schirmer MA; Grade M; Kitz J; Reuter-Jessen K; Ghadimi M; Ströbel P; Schildhaus HU; Gaedcke J
    PLoS One; 2020; 15(10):e0239806. PubMed ID: 33002027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. KRAS Mutation Predicted More Mirometastases and Closer Resection Margins in Patients with Colorectal Cancer Liver Metastases.
    Zhang Q; Peng J; Ye M; Weng W; Tan C; Ni S; Huang D; Sheng W; Wang L
    Ann Surg Oncol; 2020 Apr; 27(4):1164-1173. PubMed ID: 31720935
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Somatic Mutations in Surgically Treated Colorectal Liver Metastases: An Overview.
    Wang J; Botvinov J; Bhatt AJ; Beyer K; Kreis ME; Adam M; Alseidi A; Margonis GA
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of curcumin on apoptosis and NLRP3 inflammasome-dependent pyroptosis on colorectal cancer in vitro.
    Dal Z; Aru B
    Turk J Med Sci; 2023 Aug; 53(4):883-893. PubMed ID: 38031951
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Racial disparities in colorectal cancer clinicopathological and molecular tumor characteristics: a systematic review.
    Lawler T; Parlato L; Warren Andersen S
    Cancer Causes Control; 2024 Feb; 35(2):223-239. PubMed ID: 37688643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multimodality liver directed treatment for colorectal liver metastasis: Array of complementary options can improve outcomes - A single centre experience from India.
    Patkar S; Chopde A; Shetty N; Kulkarni S; Gala KB; Chandra D; Ramaswamy A; Ostwal V; Goel M
    Front Oncol; 2023; 13():1073311. PubMed ID: 37035190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PGC-1β and ERRα Promote Glutamine Metabolism and Colorectal Cancer Survival via Transcriptional Upregulation of PCK2.
    Frodyma DE; Troia TC; Rao C; Svoboda RA; Berg JA; Shinde DD; Thomas VC; Lewis RE; Fisher KW
    Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230802
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Embryologic Origin of the Primary Tumor and RAS Status Predict Survival after Resection of Colorectal Liver Metastases.
    Alexandrescu ST; Dinu IM; Diaconescu AS; Micu A; Pasare E; Durdu C; Dorobantu BM; Popescu I
    Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013567
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy.
    Narayan RR; Datta J; Goldman DA; Aveson VG; Walch HS; Sanchez-Vega F; Gönen M; Balachandran VP; Drebin JA; Jarnagin WR; Kingham TP; Wei AC; Schultz N; Kemeny NE; D'Angelica MI
    Ann Surg Oncol; 2022 Nov; 29(12):7579-7588. PubMed ID: 35896920
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predicting 10-year survival after resection of colorectal liver metastases; an international study including biomarkers and perioperative treatment.
    Buisman FE; Giardiello D; Kemeny NE; Steyerberg EW; Höppener DJ; Galjart B; Nierop PMH; Balachandran VP; Cercek A; Drebin JA; Gönen M; Jarnagin WR; Kingham TP; Vermeulen PB; Wei AC; Grünhagen DJ; Verhoef C; D'Angelica MI; Koerkamp BG
    Eur J Cancer; 2022 Jun; 168():25-33. PubMed ID: 35430383
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implications of RAS Mutations on Oncological Outcomes of Surgical Resection and Thermal Ablation Techniques in the Treatment of Colorectal Liver Metastases.
    Rhaiem R; Rached L; Tashkandi A; Bouché O; Kianmanesh R
    Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159083
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.